Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient

 

Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient
D

How CAR-T Cells Work, Optimal Patient for the Treatment, Axi-cel and Tisa-cel in the Real World & CARs of the Future

By Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient FEATURING David Porter
By Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient FEATURING David Porter
23 views
February 24, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Featured Video

19:39
Pfizer Hematology

The First Treatment Choice Matters

Feat. A. Ip
Update in Blood and Marrow Transplantation and Cellular Therapy
17:11

How CAR-T Cells Work, Optimal Patient for the Treatment, Axi-cel and…

Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient

D. Porter

23 views
14:48

Anemia in Hematological Malignancies: Transfusion Risk, Targets for …

Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient

P. Ford

21 views